
You took over the reins of Eli Lilly India few months ago. What have been your first impressions of the Indian ecosystem so far?
" To sustain medical progress, the biopharmaceutical industry, that takes financial risks and invests a tremendous amount of time, resources, and capital to bring life-saving treatments to patients, does need ecosystems with policies that support innovation, a pillar in tackling tomorrow’s medical challenges."
Tags: